Glembatumumab is a fully human IgG2 моноклональный антитело directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. Glembatumumab can be coupled to the microtubule ингибитор monomethyl auristatin E to form glembatumumab vedotin. Glembatumumab vedotin is an антитело-agent coupling (ADC) with antitumor activity.
Glembatumumab is a fully human IgG2 monoclonal antibody directed against the extracellular structural domain of GPNMB expressed in human breast cancer and melanoma. Glembatumumab can be coupled to the microtubule inhibitor monomethyl auristatin E to form glembatumumab vedotin. Glembatumumab vedotin is an antibody-agent coupling (ADC) with antitumor activity.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.